{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:49:46Z","timestamp":1790880586025,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre of Poland","doi-asserted-by":"publisher","award":["NN 402 523 440"],"award-info":[{"award-number":["NN 402 523 440"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education, Republic of Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jjcc.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T14:40:14Z","timestamp":1462718414000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2264-1442","authenticated-orcid":false,"given":"Agnieszka","family":"Kuchta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Strzelecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"\u0106wikli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Grucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Zdrojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kortas-Stempak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gliwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"D\u0105bkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2016.04.007_bib0170","doi-asserted-by":"crossref","first-page":"b92","DOI":"10.1136\/bmj.b92","article-title":"Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis","volume":"338","author":"Briel","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0175","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2015.02.002","article-title":"Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease","volume":"66","author":"Yamashita","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(87)90091-8","article-title":"Apolipoprotein A-I containing lipoproteins in coronary artery disease","volume":"68","author":"Puchois","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-291X(87)90451-7","article-title":"Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles","volume":"142","author":"Barbaras","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199108083250601","article-title":"A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(91)90109-G","article-title":"Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease","volume":"90","author":"Genest","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0205","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.ATV.0000022850.59845.E0","article-title":"Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I\/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction","volume":"22","author":"Luc","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2005.10.018","article-title":"LpA-I, LpA-I:A-II HDL and CHD-risk. The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial","volume":"188","author":"Asztalos","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjcard.2011.03.054","article-title":"Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease","volume":"108","author":"Guey","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1373\/clinchem.2009.139931","article-title":"High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol","volume":"56","author":"Sethi","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.atherosclerosis.2008.10.015","article-title":"Plasma pre beta1-HDL level is elevated in unstable angina pectoris","volume":"204","author":"Tashiro","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5551\/jat.11445","article-title":"Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans","volume":"19","author":"Maeda","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0235","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.84.1.129","article-title":"HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men","volume":"84","author":"Salonen","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(01)00389-8","article-title":"LpAI in HDL subfractions: serum levels in men and women with coronary heart disease and changes under hypolipemic therapy","volume":"306","author":"Nowicka","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0245","series-title":"Coronary arteriography","author":"Gensini","year":"1975"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0250","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0002-8703(05)80173-5","article-title":"A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors","volume":"119","author":"Sullivan","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0255","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-2275(20)38059-7","article-title":"Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure","volume":"23","author":"Gidez","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2362.1978.tb00832.x","article-title":"The Troms\u00f8 Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease","volume":"8","author":"Ishikawa","year":"1978","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.94.3.273","article-title":"Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Qu\u00e9bec cardiovascular study","volume":"94","author":"Lamarche","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0270","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jjcc.2015.02.005","article-title":"Different postprandial lipid metabolism and insulin resistance between non-diabetic patients with and without coronary artery disease","volume":"66","author":"Nakamura","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0275","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0002-9149(92)90856-T","article-title":"Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease","volume":"69","author":"Kwiterovich","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9150(00)00528-1","article-title":"Coronary artery disease in patients at low risk \u2013 apolipoprotein AI as an independent risk factor","volume":"155","author":"Francis","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2010.10.024","article-title":"Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort","volume":"214","author":"Williams","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.85.1.22","article-title":"Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction","volume":"85","author":"Buring","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0300","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1373\/clinchem.2003.029207","article-title":"Association of coronary heart disease with pre-beta-HDL concentrations in Japanese men","volume":"50","author":"Hattori","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.18388\/abp.2011_2237","article-title":"The origin and metabolism of a nascent pre-\u03b2 high density lipoprotein involved in cellular cholesterol efflux","volume":"58","author":"Wr\u00f3blewska","year":"2011","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2008.11.146","article-title":"Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein","volume":"379","author":"Miyazaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0315","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-9150(97)00133-0","article-title":"LpA-I levels do not reflect pre beta1-HDL levels in human plasma","volume":"133","author":"Miida","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(02)00149-1","article-title":"Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients","volume":"164","author":"Asztalos","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2006.10.017","article-title":"Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients","volume":"195","author":"Franceschini","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2016.04.007_bib0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11745-012-3750-6","article-title":"Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention","volume":"48","author":"Tian","year":"2013","journal-title":"Lipids"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:56:07Z","timestamp":1760273767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508716300569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0914508716300569"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.007","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}